mass cytometry
Maternal Blood Proteomic, Metabolomic Changes Could Predict Onset of Labor
About two to four weeks before labor starts, changes affecting the maternal metabolome, proteome, and immunome occur, a new study found.
Fluidigm CEO Chris Linthwaite said the company aims to further penetrate the diagnostic and clinical markets with both its microfluidics and mass cytometry businesses.
Fluidigm Q4 Revenues Grow 38 Percent on COVID-19-Driven Microfluidics Growth
The firm also announced a COVID-19 testing deal with George Mason University and a CyTOF supply and distribution agreement with Zhejiang PuLuoTing Health Technology in China.
The researchers identified phenotypes of SARS-CoV-2-specific T cells as well as viral epitopes involved in T cell response that could aid future vaccine design.
Fluidigm Q3 Revenues Jump 50 Percent Driven by COVID-19 Testing
Fluidigm tallied $39.9 million in revenues compared to $26.5 million a year ago, and well above analysts' consensus estimate of $32.5 million.